1. Home
  2. SHO vs OCS Comparison

SHO vs OCS Comparison

Compare SHO & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

HOLD

Current Price

$8.99

Market Cap

1.8B

ML Signal

HOLD

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

HOLD

Current Price

$24.59

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHO
OCS
Founded
1995
2003
Country
United States
Switzerland
Employees
36
3
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SHO
OCS
Price
$8.99
$24.59
Analyst Decision
Hold
Strong Buy
Analyst Count
9
6
Target Price
$9.28
$42.00
AVG Volume (30 Days)
1.4M
352.6K
Earning Date
05-05-2026
03-03-2026
Dividend Yield
4.02%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.13
$466.06
Revenue Next Year
$2.02
$502.05
P/E Ratio
$966.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.45
$14.00
52 Week High
$10.01
$30.68

Technical Indicators

Market Signals
Indicator
SHO
OCS
Relative Strength Index (RSI) 45.17 36.94
Support Level $8.70 $19.00
Resistance Level $9.37 $29.19
Average True Range (ATR) 0.21 1.26
MACD -0.02 -0.22
Stochastic Oscillator 25.89 8.20

Price Performance

Historical Comparison
SHO
OCS

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its hotel ownership segment.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Share on Social Networks: